In response to reports of shortages, the CDC issued interim guidance Dec. 14 recommending physicians prioritize flu patients at the highest risk of severe disease when treating with the antiviral oseltamivir.
Long COVID-19 has persisted as a mysterious disease affecting millions of people since the start of the pandemic. Despite this and the large number of studies that have been conducted to demystify the range of symptoms many people experience after acut…
While often the antiviral of choice among high-risk patients, a new study found nearly 15 percent of 62,525 hospitalized COVID-19 patients had a medical contraindication to Paxlovid’s antiviral combination of nirmatrelvir and ritonavir.
Nearly three-quarters of C-suite leaders at hospitals and health systems say their organizations are boosting patient outreach efforts to encourage the resumption of routine care as care delays persist, according to survey findings from consulting grou…